Metraipolis › archive › dc_62ca4caec6d8

Use of a Pathomics Signature to Predict the Prognosis of Hepatocellular Carcinoma with Cirrhosis: A Multicentre Retrospective Study — Europe PMC PMID:41097719

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41097719
DOI
10.3390/cancers17193192
License (as archived)
solo-consultazione
Archived
2026-10-08T08:57:35.514Z
SHA-256 of the archived text
47c6d7e71962a7dc2e374a761fceed519103d373bab26a3f72ecf51582f6c9b7
Stable URL of this page
https://metraipolis.com/documento/dc_62ca4caec6d8

How to cite

Use of a Pathomics Signature to Predict the Prognosis of Hepatocellular Carcinoma with Cirrhosis: A Multicentre Retrospective Study — Europe PMC PMID:41097719 — Europe PMC (en), https://europepmc.org/article/MED/41097719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62ca4caec6d8 (Metraipolis archive dc_62ca4caec6d8, sha256 47c6d7e71962a7dc2e374a761fceed519103d373bab26a3f72ecf51582f6c9b7)
BibTeX
@misc{dc62ca4caec6d8,
  title = {Use of a Pathomics Signature to Predict the Prognosis of Hepatocellular Carcinoma with Cirrhosis: A Multicentre Retrospective Study — Europe PMC PMID:41097719},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41097719},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62ca4caec6d8; sha256 47c6d7e71962a7dc2e374a761fceed519103d373bab26a3f72ecf51582f6c9b7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41097719. Agents can read the archived copy with the MCP tool read_document.